Published in:
Open Access
01-12-2010 | Oral presentation
0314. Efficacy and safety of peginterferon alfa-2a + RBV in cHCV/HIV- vs cHCV-infected patients: interim analysis of a multicenter German cohort
Authors:
A Baumgarten, T Lutz, P Kreckel, E Wellmann, U Alshuth, S Mauss, J Rockstroh
Published in:
Journal of the International AIDS Society
|
Special Issue 4/2010
Login to get access
Excerpt
Eradicating cHCV is necessary for the subsequent management of patients with HIV and every HIV/HCV co-infected patient should be considered for treatment. We describe differences between cHCV mono-infected and cHCV/HIV co-infected patients in baseline factors and outcome of cHCV-treatment with peginterferon alfa 2a + RBV in the worldwide largest cHCV cohort. …